EFMC-ASMC'17

Conferences > Upcoming events > EFMC-ASMC'17

Confirmed Speakers


Confirmed Invited Speakers

T15 - Ring Construction by Pd-catalyzed C(sp3)-H Activation
 Olivier BAUDOIN Olivier BAUDOIN
(UNIVERSITY OF BASEL, Basel, Switzerland)

Read more
T10 - Azidoperfluoroalkanes - Neglected, Stable and Useful Fluorinated Synthons
  Petr BEIER Petr BEIER
(ACADEMY OF SCIENCES OF THE CZECH REPUBLIC, Prague, Czech Republic)

Read more
Opening Lecture
T01 - Next-Generation Small Molecule Therapeutics
 James E BRADNER James E BRADNER
(NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Cambridge, MA, United States)

Read more
T03 - Drugging the Undruggable
 Mark BUNNAGE Mark BUNNAGE
(VERTEX PHARMACEUTICALS, Boston, United States)

Read more
T07 - Beta-secretase Inhibitors as a Therapy for Alzheimer’s Disease – Where Are We Now?
 Roland BÜRLI Roland BÜRLI
(ASTRAZENECA, Cambridge, United Kingdom)

Read more
T25 - More Options, More Complexity: Medicinal Chemistry Mastering Mixed Modalities
 Werngard CZECHTIZKY Werngard CZECHTIZKY
(SANOFI-AVENTIS DEUTSCHLAND GMBH, Frankfurt, Germany)

Read more
T22 - Collaborative Academic/Industrial Research Under the Umbrella of the NSF Center for Selective C-H Functionalization
 Huw DAVIES Huw DAVIES
( EMORY UNIVERSITY, Atlanta, United States)

Read more
T24 - Synthetic, Mechanistic and Computational Studies on Reactions of Interest
 Scott E. DENMARK Scott E. DENMARK
(UNIVERSITY OF ILLINOIS, Urbana, United States)

Read more
T13 - Isosteric-Switch Strategies: New Concepts and Recent Advances
 Thomas C. FESSARD Thomas C. FESSARD
(SPIROCHEM AG, Zurich, Switzerland)

Read more
T26 - DNA Repair Inhibition in Cancer Therapy: DNA-PK Inhibitor M3814
 Thomas FUCHSS Thomas FUCHSS
(MERCK KGAA, Darmstadt, Germany)

Read more
T18 - Exploiting Physical Organic Principles in Reaction Design
 Ryan GILMOUR Ryan GILMOUR
(UNIVERSITY OF MÜNSTER, Münster, Germany)

Read more
T27 - Late Stage 18F-Fluorination for PET Imaging
 Véronique GOUVERNEUR Véronique GOUVERNEUR
(UNIVERSITY OF OXFORD, Oxford, United Kingdom)

Read more
T19 - Automation, Integration and Miniaturization In Drug Discovery Synthesis
 Guido KOCH Guido KOCH
(NOVARTIS PHARMA AG, Basel, Switzerland)

Read more
T12 - When Chemistry Asks Biological Questions: Total Synthesis on the Driving Seat
 Nuno MAULIDE Nuno MAULIDE
(UNIVERSITY OF VIENNA, Vienna, Austria)

Read more
T11 - Antiviral Drug Design
 Nicholas MEANWELL Nicholas MEANWELL
(BRISTOL-MYERS SQUIBB, Wallingford, United States)

Read more
T06 - Recent Advances in Methods Development and Applications
 Gary A. MOLANDER Gary A. MOLANDER
(UNIVERSITY OF PENNSYLVANIA, Philadelphia, United States)

Read more
T08 - Idea2Data: Augmenting Drug Discovery Efforts through Synthetic Reaction Data Mining and Automation
 Christos A. NICOLAOU Christos A. NICOLAOU
(ELI LILLY, Indianapolis, United States)

Read more
T21 - With Asymmetric Hydrogenation towards a Scalable, Stereoselective Synthesis of Bitopertin
 Michelangelo SCALONE Michelangelo SCALONE
(F. HOFFMANN-LA ROCHE AG, Basel, Switzerland)

Read more
T14 - Iron(III)-Catalyzed Carbonyl-Olefin Metathesis
T17 - Adventures in Catalysis: from Mechanisms to Applications
 Franziska SCHOENEBECK Franziska SCHOENEBECK
(RWTH AACHEN, Aachen, Germany)

Read more
T23 - Strategies towards Increasing the 3-Dimensionality of the Medicinal Chemistry Design Space
 Antonia F. STEPAN Antonia F. STEPAN
(PFIZER, Cambridge, United States)

Read more
T09 - A RaPID Way to Discover Pseudo-natural Peptides for Therapeutic Uses
 Hiroaki SUGA Hiroaki SUGA
(UNIVERSITY OF TOKYO, Tokyo, Japan)

Read more
T02 - Controlling Biological Pathways With Photopharmacology
 Dirk TRAUNER Dirk TRAUNER
(NEW YORK UNIVERSITY, New York, United States)

Read more
T20 - Design and Evolution of New Biocatalysts for Organic Synthesis
 Nicholas John TURNER Nicholas John TURNER
(UNIVERSITY OF MANCHESTER, Manchester, United Kingdom)

Read more
T16 - Merck Drug Discovery through Enabling Capabilities
 Petr VACHAL Petr VACHAL
(MSD, Kenilworth, United States)

Read more
T04 - Bioinspired Asymmetric Catalysis
 Helma WENNEMERS Helma WENNEMERS
(ETH ZURICH, Zürich, Switzerland)

Read more
T05 - Strategies to Facilitate the Discovery of Novel CNS Positron Emission Tomography (PET) Ligands
 Lei ZHANG Lei ZHANG
(PFIZER, Cambridge, United States)

Read more

Oral Communications

OC09 - Development of Synthesis Strategies to DNA-Encoded Compound Libraries - of a Chemoresistant Sequence, and Micellar Nanoreactors
 Andreas BRUNSCHWEIGER Andreas BRUNSCHWEIGER
(TU DORTMUND, Dortmund, Germany)

Read more
OC06 - Expanding Screening Decks by Innovative MCR Scaffolds
 Alexander DÖMLING Alexander DÖMLING
(UNIVERSITY OF GRONINGEN, Groningen, The Netherlands)

Read more
OC02 - Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6
 Peter ETTMAYER Peter ETTMAYER
(BOEHRINGER-INGELHEIM, Vienna, Austria)

Read more
EFMC Prize for a Young Medicinal Chemist in Academia
OC10 - Nature-Derived Peptides as Pharmacological Tools to Design Novel Therapeutics
 Christian W. GRUBER Christian W. GRUBER
(MEDICAL UNIVERSITY OF VIENNA, Vienna, Austria)

Read more
EFMC Prize for a Young Medicinal Chemist in Industry:
OC11 - The Development of non-BET Bromodomain Chemical Probes
 Phil HUMPHREYS Phil HUMPHREYS
(GLAXOSMITHKLINE, Stevenage, United Kingdom)

Read more
PRIZE winner EFMC-YMCS 2016
OC04 - Development of Highly Selective and Reversible Diacylglycerol Lipase Inhibitors
 Freek JANSSEN Freek JANSSEN
(LEIDEN UNIVERSITY, Nijmegen, The Netherlands)

Read more
OC01 - Stereoselective Peptide Modifications – Efficient Tools for Natural Product and Drug Synthesis
 Uli KAZMAIER Uli KAZMAIER
(SAARLAND UNIVERSITY, Saarbrücken, Germany)

Read more
OC03 - Mimicking Nature Complexity with 3D-Fragments Assembly
 Hugues LEMOINE Hugues LEMOINE
(EDELRIS, LYON, France)

Read more
OC12 - Discovery of UCB0942, the First Rationally Designed Antiepileptic Drug with a Dual Mechanism of Action for the Treatment of Drug-Resistant Epilepsy
 Laurent PROVINS Laurent PROVINS
(UCB, Braine-l'Alleud, Belgium)

Read more
OC07 - The Discovery of Soluble Guanylate Cyclase Stimulators for the Treatment of Pulmonary Arterial Hypertension
 Subharekha RAGHAVAN Subharekha RAGHAVAN
(MSD, Kenilworth, New Jersey, United States)

Read more
OC05 - Discovery of RG7314, a Vasopressin 1a Receptor Antagonist for the Treatment of Social Communication Deficits in Autism Spectrum Disorders
 Patrick SCHNIDER Patrick SCHNIDER
(F. HOFFMANN-LA ROCHE, Basel, Switzerland)

Read more
OC08 - Exploring New Methods for Facile Synthesis of Some Biologically Interesting Molecules
 Ming-Hua XU Ming-Hua XU
(SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, Shanghai, China)

Read more

Organised by

Gold Sponsors

Silver Sponsor

Bronze Sponsors

Media Partners

Copyright 2017 LD Organisation  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 10 454777  |   |  VAT: BE 0464819842
Developed and powered by Antalys